Globular C1q Receptor (gC1qR/p32/HABP1) Is Overexpressed in Malignant Pleural Mesothelioma and Is Associated With Increased Survival in Surgical Patients Treated With ChemotherapyFrontiers in Oncology - Tập 9
Xiaoyu Li, Takashi Eguchi, Rania G. Aly, Navin K. Chintala, Kay See Tan, Marjorie G. Zauderer, Francine R. Dembitzer, Mary Beth Beasley, Berhane Ghebrehiwet, Prasad S. Adusumilli, Ellinor I.B. Peerschke
Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple MyelomaFrontiers in Oncology - Tập 12
Francesca Bonello, Serena Rocchi, Gregorio Barilà, Michela Sandrone, Marco Tallarico, Elena Zamagni, M Scaldaferri, Susanna Vedovato, Cecilia Bertiond, Laura Pavan, Sara Bringhen, Francesco Cattel, Renato Zambello, Michèle Cavo, Roberto Mina
BackgroundThe anti-CD38 monoclonal antibody daratumumab is the backbone of most anti-multiple myeloma (MM) regimens. To mitigate the risk of infusion-related reactions (IRRs), intravenous daratumumab administration requires 7 hours for the first infusion and 3.5-4 hours thereafter, thus making daratumumab-containing regimens burdensome for patients and he...... hiện toàn bộ
DNA Damage Response Proteins and Oxygen Modulate Prostaglandin E2 Growth Factor Release in Response to Low and High LET Ionizing RadiationFrontiers in Oncology - Tập 5
Chris Allen, Walter Tinganelli, Neelam Sharma, Jingyi Nie, Cory Sicard, Francesco Natale, Maurice King, Steven B. Keysar, Antonio Jimeno, Yoshiya Furusawa, Ryuichi Okayasu, Akira Fujimori, Marco Durante, Jac A. Nickoloff